Showing results (301-310 of 463) with videos related to
Sort By:
Pageof 47
Movement Disorders : Official Journal of the Movement Disorder Society|October 19, 2004
Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primatesLance A Smith, Michael J Jackson, Ghassan Al-Barghouthy, et al.Phytotherapy Research : PTR|January 26, 2018
The effect of Banisteriopsis caapi (B. caapi) on the motor deficits in the MPTP-treated common marmoset model of Parkinson's diseaseRia Fisher, Louise Lincoln, Michael J Jackson, et al.Journal of Parkinson'S Disease|September 6, 2021
Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson's Disease: A Pooled Analysis of 8 Phase 2b/3 TrialsRobert A Hauser, Nobutaka Hattori, Hubert Fernandez, et al.Nature Medicine|May 25, 2010
Missing pieces in the Parkinson's disease puzzleJose A Obeso, Maria C Rodriguez-Oroz, Christopher G Goetz, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 3, 2025
Comparative Study of Focused Ultrasound Unilateral Thalamotomy and Subthalamotomy for Medication-Refractory Parkinson's Disease TremorSteffen Paschen, Elena Natera-Villalba, José A Pineda-Pardo, et al.Brain : a Journal of Neurology|March 25, 2014
The subthalamic nucleus and inhibitory control: impact of subthalamotomy in Parkinson's diseaseIgnacio Obeso, Leonora Wilkinson, Enrique Casabona, et al.Redox Biology|February 4, 2026
Are glutathionylated aldehyde reductases the missing piece of the "catecholaldehyde hypothesis" in Parkinson's disease? A medical hypothesis concerning the detoxification of 4-hydroxynonenal (HNE) and 3,4-dihydroxyphenylacetaldehyde (DOPAL)Rossella Rotondo, Marta Russo, Federico Iacovelli, et al.Journal of Parkinson'S Disease|November 9, 2020
Continuous Subcutaneous Levodopa Delivery for Parkinson's Disease: A Randomized StudyC Warren Olanow, Alberto J Espay, Fabrizio Stocchi, et al.Neurochemical Research|July 24, 2012
Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutaseJavier Iglesias-González, Sofía Sánchez-Iglesias, Estefanía Méndez-Álvarez, et al.Journal of Neurochemistry|December 1, 2004
Pramipexole protects against apoptotic cell death by non-dopaminergic mechanismsMei Gu, M M Iravani, M Irvani, et al.Pageof 47